Literature DB >> 15727723

Treatment of the metabolic syndrome: the impact of lifestyle modification.

Allison M Pritchett1, John P Foreyt, Douglas L Mann.   

Abstract

Along with the increasing prevalence of obesity comes a constellation of metabolic derangements: dyslipidemias, hypertension, insulin resistance, and glucose intolerance, as well as increased prothrombotic and inflammatory markers. The association of these factors has been termed the "metabolic syndrome" and increases the risk of developing cardiovascular disease. Aside from pharmaceutical therapy, lifestyle modification is necessary to aggressively treat this syndrome in its entirety. This involves a holistic approach of behavioral counseling, education, increased physical activity, and dietary modification. Even modest weight loss (7% to 10% of body weight) results in decreased fat mass, blood pressure, glucose, low-density lipoprotein, and triglyceride levels. These benefits can also translate into improved long-term outcome, especially if weight loss and lifestyle alterations are maintained. However, the remaining challenge is how to promote long-term adherence to a healthier, more active lifestyle and avoid reversion to old habits.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15727723     DOI: 10.1007/s11883-005-0030-4

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  58 in total

1.  Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women.

Authors:  Ian Janssen; Anne Fortier; Robert Hudson; Robert Ross
Journal:  Diabetes Care       Date:  2002-03       Impact factor: 19.112

2.  Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT).

Authors:  Edgar R Miller; Thomas P Erlinger; Deborah R Young; Megan Jehn; Jeanne Charleston; Donna Rhodes; Sharmeel K Wasan; Lawrence J Appel
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

3.  Weight loss reduces C-reactive protein levels in obese postmenopausal women.

Authors:  André Tchernof; Amy Nolan; Cynthia K Sites; Philip A Ades; Eric T Poehlman
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

4.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.

Authors:  Katherine Esposito; Alessandro Pontillo; Carmen Di Palo; Giovanni Giugliano; Mariangela Masella; Raffaele Marfella; Dario Giugliano
Journal:  JAMA       Date:  2003-04-09       Impact factor: 56.272

5.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

6.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.

Authors:  Lawrence J Appel; Catherine M Champagne; David W Harsha; Lawton S Cooper; Eva Obarzanek; Patricia J Elmer; Victor J Stevens; William M Vollmer; Pao-Hwa Lin; Laura P Svetkey; Sarah W Stedman; Deborah R Young
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

7.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

8.  Medication cost savings associated with weight loss for obese non-insulin-dependent diabetic men and women.

Authors:  R W Collins; J W Anderson
Journal:  Prev Med       Date:  1995-07       Impact factor: 4.018

9.  High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

Authors:  A M Thögersen; J H Jansson; K Boman; T K Nilsson; L Weinehall; F Huhtasaari; G Hallmans
Journal:  Circulation       Date:  1998-11-24       Impact factor: 29.690

10.  Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.

Authors:  Donna H Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski
Journal:  Control Clin Trials       Date:  2003-10
View more
  12 in total

Review 1.  Low-carbohydrate or low-fat diets for the metabolic syndrome?

Authors:  Michael L Dansinger; Ernst J Schaefer
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

2.  Appetite-Related Gut Peptides in Obesity and Binge Eating Disorder.

Authors:  Allan Geliebter; Christopher N Ochner; Roni Aviram-Friedman
Journal:  Am J Lifestyle Med       Date:  2008-07-01

Review 3.  Differences in weight loss across different BMI classes: a meta-analysis of the effects of interventions with diet and exercise.

Authors:  Jeroen C M Barte; Jorien Veldwijk; Pedro J Teixeira; Frank M Sacks; Wanda J E Bemelmans
Journal:  Int J Behav Med       Date:  2014

4.  Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study.

Authors:  Allison M Pritchett; Anita Deswal; David Aguilar; John P Foreyt; Wenyaw Chan; Douglas L Mann; Christie Ballantyne; Biykem Bozkurt
Journal:  J Obes Weight Loss Ther       Date:  2012-03-15

5.  Short and long term effects of a lifestyle intervention for construction workers at risk for cardiovascular disease: a randomized controlled trial.

Authors:  Iris F Groeneveld; Karin I Proper; Allard J van der Beek; Vincent H Hildebrandt; Willem van Mechelen
Journal:  BMC Public Health       Date:  2011-10-31       Impact factor: 3.295

6.  Effects of a 3-Week In-Hospital Body Weight Reduction Program on Cardiovascular Risk Factors, Muscle Performance, and Fatigue: A Retrospective Study in a Population of Obese Adults with or without Metabolic Syndrome.

Authors:  Antonello E Rigamonti; Sabrina Cicolini; Diana Caroli; Alessandra De Col; Massimo Scacchi; Silvano G Cella; Alessandro Sartorio
Journal:  Nutrients       Date:  2020-05-21       Impact factor: 5.717

7.  Metabolic syndrome features and risk of neural tube defects.

Authors:  Joel G Ray; Miles D Thompson; Marian J Vermeulen; Chris Meier; Philip R Wyatt; Pui-Yuen Wong; Anne M Summers; Sandra A Farrell; David E C Cole
Journal:  BMC Pregnancy Childbirth       Date:  2007-09-19       Impact factor: 3.007

8.  Reduced fibrinogen, fibrinolytic biomarkers, and physical parameters after a weight-loss program in obese subjects.

Authors:  Che Badariah Abdul Aziz; Norsuhana Omar; Wan Zaidah Abdullah; Rohana Abdul Jalil; Wan Suriati Wan Nik; Rahimah Zakaria
Journal:  N Am J Med Sci       Date:  2014-08

9.  Short-term effects of moderate intensity physical activity in patients with metabolic syndrome.

Authors:  Caroline Macoris Colombo; Rafael Michel de Macedo; Miguel Morita Fernandes-Silva; Alexandra Moro Caporal; Andréa Emilia Stinghen; Costantino Roberto Costantini; Cristina Pellegrino Baena; Luiz Cesar Guarita-Souza; José Rocha Faria-Neto
Journal:  Einstein (Sao Paulo)       Date:  2013 Jul-Sep

10.  Can newly acquired healthy behaviors persist? An analysis of health behavior decay.

Authors:  Ray M Merrill; Steven G Aldana; Roger L Greenlaw; Hans A Diehl; Audrey Salberg; Heike Englert
Journal:  Prev Chronic Dis       Date:  2007-12-15       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.